Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001209191-24-000766

Options or other derivatives

  • Chief Business Officer acquired 79,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Jones Jullian G Chief Business Officer 2024-01-02 Grant or award · Stock Option (Right to Buy) +79,000 79,000 D: show line 1 in the form
Loading xslF345X05/doc4.xml…